Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | Lomustine
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Lomustine
*Zeyen
T, Treiber A, Schneider M, Potthoff AL, Schaub C, Roever L, Layer
JP, Gkika E, Vatter H, Paech D, Radbruch A, Schaefer N, Herrlinger
U, Weller J.
Second-line
temozolomide in first recurrent MGMT-methylated glioblastoma after
lomustine/temozolomide: Efficacy and safety.
Neurooncol
Adv. 2025 Apr
28;7(1):vdaf084. doi:
10.1093/noajnl/vdaf084. PMID:
40575419. Observational study. ˍ